DVA
DaVita·NYSE
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 3
Bearish signal 0
High Cash/net Profit Ratio
Revenue Beats Expectation
EPS Beats Expectation
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About DVA
Davita Inc.
A comprehensive kidney care provider that provides dialysis services to patients with end stage renal disease
Healthcare Providers and Services
--
11/03/1995
New York Stock Exchange
76,000
12-31
Common stock
2000 16th Street, Denver, CO 80202
--
DaVita Inc., was incorporated in Delaware in 1994. DaVita is a leading healthcare provider dedicated to transforming the way healthcare is delivered and improving the quality of life for patients around the world. The company provides care to patients at every stage and environment of their kidney health journey — from early diagnosis and prevention to supporting the transplant process.
Earnings Call
Company Financials
EPS
DVA has released its 2025 Q3 earnings. EPS was reported at 2.51, versus the expected 3.17, missing expectations. The chart below visualizes how DVA has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
DVA has released its 2025 Q3 earnings report, with revenue of 3.42B, reflecting a YoY change of 4.80%, and net profit of 240.25M, showing a YoY change of -18.77%. The Sankey diagram below clearly presents DVA's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available


